2011

Boehringer-Ingelheim (BI) stands out in its attempt to stand out from the social(ist) cookie-cutter crowd of pharma FB pages. Shows what you can do with dedicated resources and creativity.

One survey says yes, pharma reps are important to physicians, another says not so much. Who are we to believe?

A conversation with Monique Levy, VP Research at Manhattan Research, about the changing pharma eDetailing landscape. Ms. Levy discusses how the online pharma promotion landscape has changed, and which types of programs garner the largest audience as well as how the rep relationship is evolving and the role of new technologies such as tablets.

Welcome to Volume 10, Issue #4 (23 FEBRUARY 2011) of Pharma Marketing News.

Welcome to Volume 10, Issue #18 (1 DECEMBER 2011) of Pharma Marketing News.

A conversation with Michael Heinley, Corporate Vice President, Leadership and Employee Communication, and Bill Price, Vice President, Media Relations, Johnson & Johnson, about the company's Employee News Network (

The fear is that if the first steps by pharma to engage in social media conversation are too harshly scrutinized and criticized, the drug industry will shy away from getting more involved in social media.

A conversation with Monique Levy, VP Research at Manhattan Research, about the changing pharma eDetailing landscape. Ms. Levy discusses how the online pharma promotion landscape has changed, and which types of programs garner the largest audience as well as how the rep relationship is evolving and the role of new technologies such as tablets.

Lipitor Won't Go Gentle Into that Good Generic Night. Pfizer is taking a number of steps to protect it's Lipitor franchise and it hopes that many patients currently taking Lipitor will remain loyal to the brand.

No doubt you've heard that as of August 15, 2011, Facebook opened up comments on ALL pharma pages with some exceptions. That means that the pharmaceutical industry will no longer be able to shut off comments on their Facebook pages.